Opioid Use Disorder
Evidence-based medication-assisted treatment (MAT) and recovery programs for opioid addiction in New York
Opioid use disorder (OUD) is a life-threatening chronic disease affecting millions of Americans and causing over 80,000 overdose deaths annually.
The CDC reports that synthetic opioids like fentanyl now cause 70% of all opioid deaths, with 2 milligrams (a few grains of salt) being potentially fatal.
For Long Island and New York residents struggling with prescription opioids, heroin, or fentanyl addiction, medication-assisted treatment (MAT) combined with therapy offers the strongest evidence-based path to recovery. Medication options include daily buprenorphine, methadone, naltrexone, and long-acting injectables such as Brixadi weekly and monthly injections.
Key Takeaways: Opioid Use Disorder Essentials
2mg can be fatal. Most heroin and counterfeit pills now contain fentanyl. Always carry Narcan (naloxone).
Buprenorphine, methadone, and naltrexone are FDA-approved medications that work. MAT is the gold standard for opioid addiction.
Medical detox with buprenorphine or methadone dramatically reduces suffering and prevents early relapse.
Millions are in long-term recovery from opioid addiction. Evidence-based MAT + therapy achieves lasting sobriety.
The Four Waves of the Opioid Crisis
Understanding how the opioid epidemic evolved and why medication-assisted treatment saves lives
Prescription Opioid Wave
1990s-2010OxyContin marketing leads to widespread prescription opioid addiction
Heroin Wave
2010-2013Prescription restrictions push users to cheaper heroin
Synthetic Opioid Wave
2013-2020Illicit fentanyl floods drug supply
Polysubstance Wave
2020-PresentFentanyl mixed with stimulants (meth, cocaine)
MAT Reduces Overdose Deaths by 50%
Get help with opioid addiction today
Call: 844-338-6969
The Opioid Crisis by Numbers
Understanding the scope of opioid addiction
Opioid Withdrawal Timeline
Understanding what to expect during opioid detox helps prepare for recovery
Early Withdrawal
8-24 hoursPeak Symptoms
24-72 hoursGradual Improvement
72 hours - 7 daysPost-Acute Phase
1-4 weeksMAT Makes Withdrawal Manageable
Medication-assisted treatment with buprenorphine or methadone eliminates most withdrawal symptoms and reduces cravings by 80%.
Get help with opioid withdrawal today
Call: 844-338-6969
What Are Opioids and How Do They Cause Addiction?
Opioids are a class of drugs that include prescription pain relievers (oxycodone, hydrocodone, morphine, fentanyl patches), codeine-based cough syrups misused as lean (codeine-promethazine "dirty sprite"), and illegal drugs like heroin and illicitly manufactured fentanyl.
According to NIDA research, opioids bind to receptors in the brain, spinal cord, and body, blocking pain signals and producing euphoria. With repeated use, the brain adapts by reducing natural opioid production and increasing receptor sensitivity—creating physical dependence and tolerance.
The opioid overdose crisis in New York: According to New York OASAS data, 85% of opioid overdose deaths in 2022 involved fentanyl, up from 45% in 2017. The shift from heroin to illicit fentanyl has made overdose vastly more likely.
Why is fentanyl so deadly? Fentanyl is 50-100 times stronger than morphine. Just 2 milligrams—equivalent to a few grains of salt—can be fatal. Illicit fentanyl is mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills without users knowing. Overdose occurs rapidly, often within minutes, causing respiratory arrest before help can arrive.
Opioid Withdrawal Timeline & Symptoms
| Time Since Last Use | Physical Symptoms | Psychological Symptoms |
|---|---|---|
6-12 hours (short-acting) | Muscle aches, sweating, runny nose, watery eyes, yawning | Anxiety, restlessness, irritability, cravings |
24-48 hours (long-acting) | Increased heart rate, high blood pressure, dilated pupils, goosebumps | Severe anxiety, agitation, difficulty concentrating |
1-3 days (peak) | Severe nausea, vomiting, diarrhea, abdominal cramping, fever, rapid heartbeat | Intense cravings, depression, insomnia, suicidal thoughts |
5-10 days | Symptoms gradually subside. Fatigue, muscle aches, sleep disturbances persist | Depression, anhedonia (inability to feel pleasure), cravings |
Weeks to months | Post-acute withdrawal: low energy, sleep problems, mild aches | Mood swings, anxiety, depression, persistent cravings |
Note: Medical detox with buprenorphine or methadone eliminates 70-90% of withdrawal symptoms. Most patients describe medically assisted withdrawal as "uncomfortable but manageable" rather than "excruciating."
FDA-Approved Medications for Opioid Use Disorder
| Medication | Mechanism of Action | Effectiveness | FDA Status |
|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade) | Partial opioid agonist blocking withdrawal and cravings without euphoria | Reduces overdose death risk by 50%. Doubles treatment retention vs therapy alone. | FDA-Approved |
| Methadone | Long-acting full opioid agonist eliminating withdrawal and cravings | Oldest MAT medication. Effective for severe OUD. Requires daily clinic visits. | FDA-Approved |
| Naltrexone (Vivitrol injection) | Opioid antagonist blocking euphoric effects if relapse occurs | Effective post-detox. Monthly injection improves medication adherence. | FDA-Approved |
Source: FDA Medication-Assisted Treatment Information and SAMHSA TIP 63: Medications for Opioid Use Disorder
Why Medication-Assisted Treatment (MAT) Is Essential
Medication-assisted treatment (MAT) is the gold standard for opioid use disorder according to SAMHSA, NIDA, and the American Society of Addiction Medicine (ASAM).
Research published in BMJ shows that MAT with buprenorphine or methadone reduces overdose death risk by 50% compared to behavioral therapy alone. Patients on MAT are also twice as likely to remain in treatment long-term.
How Buprenorphine Works
Buprenorphine (Suboxone, Sublocade) is a partial opioid agonist that occupies opioid receptors without producing dangerous euphoria or respiratory depression. It eliminates withdrawal symptoms and cravings while allowing patients to function normally at work, school, and family life.
Buprenorphine has a ceiling effect: Taking higher doses does not increase euphoria or respiratory risk, making it far safer than full agonist opioids. Most patients take buprenorphine long-term (1-2+ years) as maintenance therapy.
Methadone Programs
Methadone is a long-acting full opioid agonist that eliminates withdrawal and cravings for 24-36 hours. Methadone treatment requires daily visits to a certified opioid treatment program (OTP) for observed dosing, which provides structure and accountability.
Methadone is particularly effective for severe, long-term opioid addiction where buprenorphine has not been successful.
Naltrexone for Relapse Prevention
Naltrexone (Vivitrol monthly injection) is an opioid blocker that prevents euphoria if a patient relapses. Unlike buprenorphine and methadone, naltrexone is not an opioid and has no abuse potential. However, patients must complete full detoxification before starting naltrexone (7-10 days opioid-free).
Treatment Path for Opioid Addiction
Get Immediate Help
24/7 crisis support for opioid overdose, withdrawal, and treatment placement in New York and Long Island.
Call 844-338-6969Frequently Asked Questions
Medical References & Sources
This page contains information sourced from peer-reviewed medical literature, federal health agencies, and accredited medical institutions to ensure accuracy and compliance with E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) standards.
- Centers for Disease Control and Prevention (CDC). "Understanding the Opioid Overdose Epidemic." CDC National Center for Injury Prevention and Control, 2023. Available at: https://www.cdc.gov/opioids/basics/epidemic.html
- National Institute on Drug Abuse (NIDA). "Opioid Overdose Crisis: Prescription Opioids." NIDA Research Publications, 2023. Available at: https://nida.nih.gov/research-topics/opioids
- Substance Abuse and Mental Health Services Administration (SAMHSA). "Medications for Opioid Use Disorder: Treatment Improvement Protocol (TIP) 63." SAMHSA Publications, 2023. Available at: https://store.samhsa.gov/sites/default/files/pep21-02-01-002.pdf
- U.S. Food and Drug Administration (FDA). "FDA-Approved Medications for Medication-Assisted Treatment of Opioid Use Disorder." FDA Center for Drug Evaluation and Research, 2024. Available at: https://www.fda.gov/drugs/information-drug-class/information-about-medication-assisted-treatment-mat
- New York State Office of Addiction Services and Supports (OASAS). "Opioid Overdose Prevention and Naloxone Access in New York." OASAS Data Portal, 2024. Available at: https://oasas.ny.gov/naloxone
- Sordo L, Barrio G, Bravo MJ, et al.. "Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies." BMJ, 2017 DOI: 10.1136/bmj.j1550. Available at: https://www.bmj.com/content/357/bmj.j1550
- Volkow ND, Jones EB, Einstein EB, Wargo EM. "Prevention and Treatment of Opioid Misuse and Addiction: A Review." JAMA Psychiatry, 2019 DOI: 10.1001/jamapsychiatry.2018.3126. Available at: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2718619
Medical Disclaimer
The information provided on this page is for educational purposes only and should not be considered medical advice. This page does not provide medical diagnoses, treatment prescriptions, or clinical recommendations. Always consult with qualified healthcare professionals for diagnosis and treatment of substance use disorders. If you are experiencing a medical emergency, call 911 immediately.
This content was written by certified addiction professionals and reviewed by licensed medical practitioners to ensure accuracy and adherence to current clinical guidelines. Last fact-checked: October 25, 2026.
If you or someone you know is struggling with substance use, you can reach our 24/7 confidential Long Island Rehab Helpline at 844-338-6969 for free, confidential information and treatment referral.